-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
"Is the new crown vaccine effective against the newly emerging mutant virus?" "Is the new crown vaccine the same as the flu vaccine? Will it be shot every year?" As the new crown vaccine is widely spread around the world, these questions about the protective efficacy and durability of the new crown vaccine Doubts have been lingering.
Previously, the data released when BNT162b2 was reviewed by the FDA was based on the evaluation of 170 COVID-19 patients with symptoms.
In terms of preventing serious diseases, the latest results also provide more information.
A number of previous studies have shown that the new coronavirus strain B.
Although the number of patients in clinical trials conducted in South Africa is small, and the protective effect of B.
In terms of safety, more than 12,000 volunteers who received two doses of the vaccine have been followed up for at least 6 months and no serious safety problems have been found.
Note: The original text has been deleted
Reference materials:
[1] Pfizer and BioNTech Confirm High Efficacy and No Serious Safety Concerns Through Up to Six Months Following Second Dose in Updated Topline Analysis of Landmark COVID-19 Vaccine Study.
[2] Liu et al.
[3] Eric Topol.
